The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Hanauer, Stephen
One or more keywords matched the following items that are connected to Hanauer, Stephen
Item TypeName
Concept Anti-Inflammatory Agents, Non-Steroidal
Concept Anti-Inflammatory Agents
Academic Article Review article: the medical management of Crohn's disease.
Academic Article Cyclosporin for severe ulcerative colitis: a user's guide.
Academic Article Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group.
Academic Article Medical therapy for inflammatory bowel disease.
Academic Article Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.
Academic Article Dose-ranging study of mesalamine (PENTASA) enemas in the treatment of acute ulcerative proctosigmoiditis: results of a multicentered placebo-controlled trial. The U.S. PENTASA Enema Study Group.
Academic Article Evolving treatment strategies for inflammatory bowel disease.
Academic Article A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
Academic Article Comparative tolerability of treatments for inflammatory bowel disease.
Academic Article Balsalazide led to greater remission rates and tolerance than mesalamine in acute ulcerative colitis.
Academic Article Budesonide CIR capsules (once or twice daily divided-dose) in active Crohn's disease: a randomized placebo-controlled study in the United States.
Academic Article Update on medical management of inflammatory bowel disease: ulcerative colitis.
Academic Article Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis.
Academic Article Long-term use of mesalamine (Rowasa) suppositories in remission maintenance of ulcerative proctitis.
Academic Article Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.
Academic Article Efficacy and safety of oral ridogrel in the treatment of ulcerative colitis: two multicentre, randomized, double-blind studies.
Academic Article Systematic review: the pharmacokinetic profiles of oral mesalazine formulations and mesalazine pro-drugs used in the management of ulcerative colitis.
Academic Article A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.
Academic Article Crohn's disease: step up or top down therapy.
Academic Article Repifermin (keratinocyte growth factor-2) for the treatment of active ulcerative colitis: a randomized, double-blind, placebo-controlled, dose-escalation trial.
Academic Article Mesalamine derivatives in the treatment of Crohn's disease.
Academic Article Oral Pentasa in the treatment of active Crohn's disease: A meta-analysis of double-blind, placebo-controlled trials.
Academic Article Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.
Academic Article Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.
Academic Article Treatment of ulcerative colitis with balsalazide: response to Drs Johnson, Green, and Pruitt.
Academic Article Caution in the interpretation of safety and efficacy differences in clinical trials comparing aminosalicylates for ulcerative colitis.
Academic Article Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease.
Academic Article Semantics.
Academic Article New lessons: classic treatments, expanding options in ulcerative colitis.
Academic Article A randomized, placebo-controlled, phase II study of tetomilast in active ulcerative colitis.
Academic Article Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.
Academic Article Refining the role of TNF antagonists for Crohn's disease. Introduction.
Academic Article Comparative analysis of the in vitro prosecretory effects of balsalazide, sulfasalazine, olsalazine, and mesalamine in rabbit distal ileum.
Academic Article Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
Academic Article Review article: evolving concepts in treatment and disease modification in ulcerative colitis.
Academic Article Controversies with aminosalicylates in inflammatory bowel disease.
Academic Article Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts.
Academic Article Selecting appropriate anti-TNF agents in inflammatory bowel disease.
Academic Article Optimizing conventional therapies for inflammatory bowel disease.
Academic Article General principles and pharmacology of biologics in inflammatory bowel disease.
Academic Article Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab.
Academic Article Maintenance therapy with certolizumab pegol for Crohn's disease.
Academic Article An evidence-based systematic review on medical therapies for inflammatory bowel disease.
Academic Article Aminosalicylates for induction of remission or response in Crohn's disease.
Academic Article Adalimumab sustains steroid-free remission after 3 years of therapy for Crohn's disease.
Academic Article Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.
Academic Article Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial.
Academic Article Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
Academic Article Treatment of inflammatory bowel disease: a review of medical therapy.
Academic Article Disease modification in inflammatory bowel disease.
Academic Article Update on the management of ulcerative colitis.
Academic Article Efficacy of topical 5-aminosalicylates in preventing relapse of quiescent ulcerative colitis: a meta-analysis.
Academic Article Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Academic Article The case for using 5-aminosalicyclates in Crohn's disease: pro.
Academic Article The management of ulcerative colitis.
Academic Article Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group.
Academic Article Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
Academic Article Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis.
Academic Article The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response?
Academic Article Clinical scenarios in IBD: optimizing the use of conventional and biologic agents.
Academic Article 5-ASA enema therapy.
Academic Article Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
Academic Article Pilot feasibility studies of leukocytapheresis with the Adacolumn Apheresis System in patients with active ulcerative colitis or Crohn disease.
Academic Article Quality-of-life results of double-blind, placebo-controlled trial of mesalamine in patients with Crohn's disease.
Academic Article Delayed-release oral mesalamine 4.8 g/day (800 mg tablets) compared to 2.4 g/day (400 mg tablets) for the treatment of mildly to moderately active ulcerative colitis: The ASCEND I trial.
Academic Article Crohn's disease. The problem and its management.
Academic Article Conventional treatment in inflammatory bowel disease--recent trends. Immunosuppressants and biologic agents: should they or need they be used together? How to use immunosuppressive therapy better (and safer) tomorrow?
Academic Article Inflammatory bowel disease.
Academic Article Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.
Academic Article Can we treat ulcerative colitis with nutritional supplements?
Academic Article Commentary: pre-operative use of anti-TNF-a agents and the risk of post-operative complications in patients with ulcerative colitis.
Academic Article Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.
Academic Article Medical therapy to reduce postoperative Crohn's disease recurrence.
Academic Article A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
Academic Article Budesonide for maintenance of remission in patients with Crohn's disease in medically induced remission: a predetermined pooled analysis of four randomized, double-blind, placebo-controlled trials.
Academic Article Review article: high-dose aminosalicylates to induce and maintain remissions in ulcerative colitis.
Academic Article Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease.
Academic Article Mea culpa.
Academic Article Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's disease.
Academic Article Early symptomatic response and mucosal healing with mesalazine rectal suspension therapy in active distal ulcerative colitis--additional results from two controlled studies.
Academic Article Heading back to the trough (levels of biologics in IBD).
Academic Article Still in pursuit.
Academic Article Effects of vedolizumab induction therapy for patients with Crohn's disease in whom tumor necrosis factor antagonist treatment failed.
Academic Article Aminosalicylates for induction of remission or response in Crohn's disease.
Academic Article Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
Academic Article Using Proactive Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease: From an Old Concept to a Future Standard of Care?
Academic Article Too Soon to Discard 5-ASAs?
Academic Article Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials.
Academic Article Checkpoint Inhibitor-Induced Colitis.
Academic Article Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis.
Academic Article Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes.
Academic Article Review article: drug-induced small bowel injury.
Search Criteria
  • Anti Inflammatory Agents